Floatz logo

Catequentinib

Pemetrexed

The First People's Hospital of LianyungangSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

5 Active assets in the Pemetrexed cohort.

Asset / SponsorPhaseRating
Befotertinib
Peng Zhang
Phase 2CCC
CIS-DIAMMINEDICHLOROPLATINUM II
Guangzhou Medical University
Phase 1/2CC
Iparomlimab
Guangzhou Medical University
Phase 1/2CC
ETOPOSIDE
Guangzhou Medical University
Phase 1/2CC
Carboplatin
Guangzhou Medical University
Phase 1/2CC

Same molecule, other indications

Catequentinib is also rated in:

AnlotinibDormant
BB
Indicative ·
71 / 100
View asset →
refractory malignant neoplasmDormant
BB
Indicative ·
70 / 100
View asset →
kidney cancerDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →